Blog
RSS FeedPosted by Michael Wonder on 20 Jul 2023
Changes to CADTH’s rapid response service
20 July 2023 - As CADTH continues along the path of strategic transformation, we’re working hard to align the evidence products ...
Posted by Michael Wonder on 18 Mar 2020
COVID-19: an update from Dr. Brian O’Rourke, CADTH President and CEO
18 March 2020 - As our country deals with the COVID-19 situation, CADTH has implemented several initiatives to mitigate the ...
Posted by Michael Wonder on 25 Mar 2019
One Canadian payer's experience with biosimilars
25 March 2019 - Much of the discussion about biosimilar uptake revolves around challenges in the United States, but other ...
Posted by Michael Wonder on 04 Apr 2018
What should and shouldn’t be covered by Medicare?
3 April 2018 - When you or a family member falls gravely ill or suffers a serious injury, the learning ...
Posted by Michael Wonder on 10 May 2017
Provincial drug plans, including Ontario and BC, make Entyvio (vedolizumab) available to treat inflammatory bowel disease
9 May 2017 - Gut-selective treatment now funded publicly for Canadians with ulcerative colitis and Crohn's disease. ...